Fig 1.
Overall study design.
Fig 2.
Retrospective cohort analysis study design.
Table 1.
Patient characteristics.
Fig 3.
Retrospective cohort analysis results.
Table 2.
Number of significantly enriched pathways for amphetamine, number of significantly enriched pathways shared between amphetamine and PD, and list of shared pathways.